StockData
Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH) stock

ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$102.09+0.68 (+0.67%)

Close on Nov 17, 2026Market cap $19.47BP/E 24.8Yield 0.94%

Zimmer Biomet total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Zimmer Biomet's total debt was $7.48B at Jun 30, 2026. For fiscal 2025 it was $7.52B, up 21.2% from the year before. Over ten years it grew -4.2% a year on average. The highest annual figure on record is $11.50B in fiscal 2015.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.52B+21.2%
FY2024Dec 31, 2024$6.20B+7.6%
FY2023Dec 31, 2023$5.77B+1.3%
FY2022Dec 31, 2022$5.70B-19.4%
FY2021Dec 31, 2021$7.07B-13.0%
FY2020Dec 31, 2020$8.13B-1.2%
FY2019Dec 31, 2019$8.22B-8.0%
FY2018Dec 31, 2018$8.94B-11.9%
FY2017Dec 31, 2017$10.14B-9.8%
FY2016Dec 31, 2016$11.24B-2.2%
FY2015Dec 31, 2015$11.50B+706.6%
FY2014Dec 31, 2014$1.43B-14.8%
FY2013Dec 31, 2013$1.67B-8.1%
FY2012Dec 31, 2012$1.82B+5.9%
FY2011Dec 31, 2011$1.72B+50.5%
FY2010Dec 31, 2010$1.14B+1.3%
FY2009Dec 31, 2009$1.13B+145.1%
FY2008Dec 31, 2008$460.10M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.48B-1.2%
Q1 FY2026Mar 31, 2026$7.47B+4.1%
Q4 FY2025Dec 31, 2025$7.52B+21.2%
Q3 FY2025Sep 30, 2025$8.11B+25.8%
Q2 FY2025Jun 30, 2025$7.57B+29.8%
Q1 FY2025Mar 31, 2025$7.18B+23.8%
Q4 FY2024Dec 31, 2024$6.20B+7.6%
Q3 FY2024Sep 30, 2024$6.45B+17.7%
Q2 FY2024Jun 30, 2024$5.83B+2.2%
Q1 FY2024Mar 31, 2024$5.80B+0.1%
Q4 FY2023Dec 31, 2023$5.77B+1.3%
Q3 FY2023Sep 30, 2023$5.48B-4.1%
Q2 FY2023Jun 30, 2023$5.71B-5.2%
Q1 FY2023Mar 31, 2023$5.79B-8.1%
Q4 FY2022Dec 31, 2022$5.70B-19.4%
Q3 FY2022Sep 30, 2022$5.71B-23.8%
Q2 FY2022Jun 30, 2022$6.02B-23.3%
Q1 FY2022Mar 31, 2022$6.30B-19.6%
Q4 FY2021Dec 31, 2021$7.07B-13.0%
Q3 FY2021Sep 30, 2021$7.50B-9.5%
Q2 FY2021Jun 30, 2021$7.85B-4.3%
Q1 FY2021Mar 31, 2021$7.84B-19.0%
Q4 FY2020Dec 31, 2020$8.13B-1.2%
Q3 FY2020Sep 30, 2020$8.29B-0.7%
Q2 FY2020Jun 30, 2020$8.21B-5.8%
Q1 FY2020Mar 31, 2020$9.67B+9.8%
Q4 FY2019Dec 31, 2019$8.22B-8.0%
Q3 FY2019Sep 30, 2019$8.35B-9.3%
Q2 FY2019Jun 30, 2019$8.72B-8.3%
Q1 FY2019Mar 31, 2019$8.81B-20.7%
Q4 FY2018Dec 31, 2018$8.94B-11.9%
Q3 FY2018Sep 30, 2018$9.20B-11.8%
Q2 FY2018Jun 30, 2018$9.51B-11.0%
Q1 FY2018Mar 31, 2018$11.11B-3.5%
Q4 FY2017Dec 31, 2017$10.14B-9.8%
Q3 FY2017Sep 30, 2017$10.42B-10.0%
Q2 FY2017Jun 30, 2017$10.68B–
Q1 FY2017Mar 31, 2017$11.51B–
Q4 FY2016Dec 31, 2016$11.24B–
Q3 FY2016Sep 30, 2016$11.58B–

More Zimmer Biomet figures

See a number that looks wrong?